drug prices

Consumers will have a new generic alternative to the widely used — and pricey — device to counter life-threatening allergic reactions.

The pharmaceutical company says it will delay price increases that went into effect on July 1. The move follows pressure from President Trump.

Sometimes a drug plan's copay is higher than the cash price, but insurance rules keep pharmacists from telling Medicare beneficiaries unless they ask.

Celgene Corp. has thwarted rival drugmakers eager to make cheaper versions of medicines for a form of blood cancer. Now administration officials are criticizing practices they say hold generics back.

After criticism that the administration's blueprint for drug prices was vague, the secretary of health and human services zeroed in on actions that he said need only his signature.

The Trump administration rolled out a list of actions in its budget proposal to attack drug prices, but most of the measures dance around the edges of the problem.

The Pharmaceutical Research and Manufacturers of America, the brand-name drug industry's main trade group, spent liberally to shift the conversation on prices during the last presidential campaign.

The National Academies of Sciences, Engineering and Medicine get very specific in their recommendations of actions they think the federal government should take to lower prescription drug costs.

In odd-numbered years, Election Day is a hodgepodge of races. But in an era when all politics is national, these low-profile elections have a lot to say about the direction of the country.

Ohio voters are being asked by a ballot initiative to consider making a law that would require the state to pay no more for prescription drugs than the federal Department of Veterans Affairs does.